Cargando…
Imaging as a surrogate marker of drug efficacy in cardiovascular disease
Autores principales: | Tarkin, Jason M, Dweck, Marc R, Rudd, James H F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580750/ https://www.ncbi.nlm.nih.gov/pubmed/30381320 http://dx.doi.org/10.1136/heartjnl-2017-311213 |
Ejemplares similares
-
Myocardial fibrosis: why image, how to image and clinical implications
por: Bing, Rong, et al.
Publicado: (2019) -
Timing of intervention in aortic stenosis: a review of current and future strategies
por: Everett, Russell James, et al.
Publicado: (2018) -
Assessment and management of cardiovascular disease in the intensive care unit
por: Cook, David Jonathan, et al.
Publicado: (2022) -
Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice
por: Agca, Rabia, et al.
Publicado: (2022) -
Optimal diet for cardiovascular and planetary health
por: Verschuren, W M Monique, et al.
Publicado: (2022)